RecruitingNot ApplicableNCT06935513
Wearable Devices Empowering Active Health Initiatives for High-Risk Stroke Populations
Sponsor
Affiliated Hospital of Nantong University
Enrollment
300 participants
Start Date
Apr 20, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
The purpose of this study is to evaluate the control effect of smart wearable devices on key risk factors in the high-risk populations for stroke
Eligibility
Min Age: 30 Years
Inclusion Criteria7
- Diagnosed with hypertension;
- Diagnosed with diabetes;
- Diagnosed with atrial fibrillation;
- Smoking subjects;
- Physical inactive subjects；
- Obesity and overweight subjects;
- Must be able to use smart wearable devices.
Exclusion Criteria4
- Diagnosed with malignancies;
- Diagnosed with psychiatric disorders;
- Diagnosed with cognitive impairment;
- Unable to operate smart wearable devices.
Interventions
BEHAVIORALWearable Devices
Participants utilize wearable devices (smart wristbands) 24 hours a day for 6 months. Wearable devices can provide medication reminders for each use and heart rate monitoring.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06935513
Related Trials
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
NCT070644731153 locations
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
NCT0605963898 locations
OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP)
NCT052937561 location
Coaching and Navigation by Community Health Workers (CHWs) Through Telehealth for High-risk Hypertension
NCT074614154 locations
A Registry on the FARAVIEW Technology of the OPAL HDx Mapping System When Used With the FARAWAVE NAV Ablation Catheter in the Treatment of Atrial Fibrillation
NCT0680821732 locations